InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Sinclair Michael, Director. Insider active across 1 company, notably Opiant Pharmaceuticals, INC.. Aggregated, 7 disclosures have been recorded. Split: 0 buy · 4 sells. Total volume traded: €368k. Activity tracked since 23 August 2021. The latest transaction was disclosed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
27,450 shares@ US$20.0035.8% of flowCommon StockSEC:0001385508-23-000063:0
5,491 shares@ US$11.096.3% of flowCommon StockSEC:0001385508-22-000092:0
7,896 shares@ US$12.259.9% of flowCommon StockSEC:0001385508-22-000074:0
7,688 shares@ US$12.9410.1% of flowCommon StockSEC:0001385508-22-000072:0
9,736 shares@ US$13.8813.6% of flowCommon StockSEC:0001385508-22-000068:0
65,124 shares@ US$5.0030.0% of flowCommon Stock, par value $0.001 per shareSEC:0001385508-21-000119:0
65,124 shares@ US$5.0019.3% of flowCommon Stock, par value $0.001 per shareSEC:0001385508-21-000119
7 of 7 declarations
About Sinclair Michael
Michael Sinclair is a Board Member of Opiant Pharmaceuticals, Inc. As a board member, he participates in strategic decision-making and oversight of the company's operations. Sinclair brings valuable expertise in the pharmaceutical sector, helping to guide direction and ensure compliance with regulations. His role is essential in ensuring good governance at Opiant Pharmaceuticals.
